Gabor F.
- Country
- Hungary
- Department
- Pszichiatria
Research Overview
- Long-term Safety and Tolerability Evaluation of Emraclidine in Adult Patients with Schizophrenia: A 52-week, Phase 2, Open-label Clinical Trial
- Efficacy and Safety of Aticaprant as Adjunctive Therapy in Adults with Major Depressive Disorder and Anhedonia Unresponsive to Antidepressants
- Efficacy and Safety of Evenamide as an Adjunctive Treatment in Patients with Treatment-Resistant Schizophrenia on Stable Antipsychotic Therapy
Data & Insights
Has run more than one trial at 67 of 194 partner sites.
Specializations
Psychiatric Disorders
This investigator specializes in treating severe psychiatric conditions, with particular emphasis on schizophrenia and major depressive disorder.
- Schizophrenia Management
- Depression Treatment
- Anhedonia Studies
The investigator's work encompasses novel therapeutic approaches for treatment-resistant cases and long-term management strategies.
Therapeutic Focus
Primary concentration on innovative treatments including adjunctive therapy approaches and antidepressant augmentation strategies.
- Novel Psychiatric Medications
- Long-term Safety Evaluation
- Treatment Resistance
The investigator examines therapeutic interventions for patients who show inadequate response to conventional treatments.
Clinical Expertise
Specialized focus on moderate-to-severe psychiatric symptoms and their management through targeted therapeutic approaches.
- Symptom Management
- Treatment Tolerability
- Long-term Patient Care
The investigator's practice emphasizes comprehensive psychiatric care with attention to safety and efficacy outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.